Related Experiment Video
Updated: Feb 22, 2026

07:29
Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
Published on: November 12, 2015
20.5K
Pathophysiology of Keratoconus: What Do We Know Today
Uri Soiberman1, James W Foster1, Albert S Jun1
1Cornea Division, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, USA.
The Open Ophthalmology Journal
|September 22, 2017
Summary
Keratoconus, a corneal disease causing vision loss, involves unclear pathogenic pathways. This review connects early morphological findings with current proteomic and cell studies to explore disease mechanisms.
Area of Science:
- Ophthalmology
- Corneal Diseases
- Pathology
Background:
- Keratoconus is a progressive corneal ectasia causing significant visual impairment.
- Abnormal protein expression is observed in keratoconic corneas, but disease mechanisms remain unclear.
- Existing research highlights morphological changes, yet a comprehensive understanding of pathogenesis is lacking.
Purpose of the Study:
- To review morphological studies of the keratoconic cornea.
- To correlate early morphological findings with current proteomic, biochemical, and cell culture data.
- To propose potential pathogenic pathways for keratoconus.
Main Methods:
- Literature review of morphological, proteomic, biochemical, and cell culture studies on keratoconus.
- Synthesis of findings from diverse study types.
- Postulation of pathogenic mechanisms based on integrated data.
Main Results:
- Morphological alterations in keratoconus provide foundational insights.
- Proteomic and biochemical studies reveal specific protein dysregulations.
- Cell culture models offer functional context for observed molecular changes.
Conclusions:
- Integrating morphological, molecular, and cellular data is crucial for understanding keratoconus.
- Specific pathogenic pathways involving protein abnormalities and cellular dysfunction are suggested.
- Further research is needed to elucidate and validate these pathways for therapeutic development.
Keywords:
Corneal epitheliumCytokineKeratoconusKeratocytesMorphologyOxidative stressPathogenesisProteomicsTGF-βMore Related Videos
Related Concept Videos
Glaucoma: Overview
1.5K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.5K
Photoreceptors and Visual Pathways
9.5K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
9.5K
Chronic Kidney Disease I: Introduction
827
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
827

